265 related articles for article (PubMed ID: 20461965)
1. Basophil activation can predict clinical sensitivity in patients after venom immunotherapy.
Kucera P; Cvackova M; Hulikova K; Juzova O; Pachl J
J Investig Allergol Clin Immunol; 2010; 20(2):110-6. PubMed ID: 20461965
[TBL] [Abstract][Full Text] [Related]
2. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy.
Erdmann SM; Sachs B; Kwiecien R; Moll-Slodowy S; Sauer I; Merk HF
Allergy; 2004 Oct; 59(10):1102-9. PubMed ID: 15355470
[TBL] [Abstract][Full Text] [Related]
3. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy.
Eberlein-König B; Schmidt-Leidescher C; Rakoski J; Behrendt H; Ring J
J Investig Allergol Clin Immunol; 2006; 16(1):5-10. PubMed ID: 16599242
[TBL] [Abstract][Full Text] [Related]
4. Use of CD63 expression as marker of in vitro basophil activation in identifying the culprit in insect venom allergy.
Eberlein-König B; Rakoski J; Behrendt H; Ring J
J Investig Allergol Clin Immunol; 2004; 14(1):10-6. PubMed ID: 15160437
[TBL] [Abstract][Full Text] [Related]
5. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.
Ebo DG; Hagendorens MM; Schuerwegh AJ; Beirens LM; Bridts CH; De Clerck LS; Stevens WJ
Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386
[TBL] [Abstract][Full Text] [Related]
6. High sensitivity of basophils predicts side-effects in venom immunotherapy.
Kosnik M; Silar M; Bajrovic N; Music E; Korosec P
Allergy; 2005 Nov; 60(11):1401-6. PubMed ID: 16197472
[TBL] [Abstract][Full Text] [Related]
7. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study.
Sturm GJ; Böhm E; Trummer M; Weiglhofer I; Heinemann A; Aberer W
Allergy; 2004 Oct; 59(10):1110-7. PubMed ID: 15355471
[TBL] [Abstract][Full Text] [Related]
8. A new variant of the basophil activation test for allergen-induced basophil CD63 upregulation. The effect of cetirizine.
Wolanczyk-Medrala A; Gogolewski G; Liebhart J; Gomulka K; Litwa M; Panaszek B; Lindner K; Medrala W
J Investig Allergol Clin Immunol; 2009; 19(6):465-73. PubMed ID: 20128421
[TBL] [Abstract][Full Text] [Related]
9. Basophil sensitivity in patients not responding to venom immunotherapy.
Peternelj A; Silar M; Erzen R; Kosnik M; Korosec P
Int Arch Allergy Immunol; 2008; 146(3):248-54. PubMed ID: 18270492
[TBL] [Abstract][Full Text] [Related]
10. Comparison of basophil activation tests using CD63 or CD203c expression in patients with insect venom allergy.
Eberlein-König B; Varga R; Mempel M; Darsow U; Behrendt H; Ring J
Allergy; 2006 Sep; 61(9):1084-5. PubMed ID: 16918511
[TBL] [Abstract][Full Text] [Related]
11. Monitoring honeybee venom immunotherapy in children with the basophil activation test.
Žitnik SE; Vesel T; Avčin T; Šilar M; Košnik M; Korošec P
Pediatr Allergy Immunol; 2012 Mar; 23(2):166-72. PubMed ID: 22136583
[TBL] [Abstract][Full Text] [Related]
12. Expression of activation markers on basophils in a controlled model of anaphylaxis.
Gober LM; Eckman JA; Sterba PM; Vasagar K; Schroeder JT; Golden DB; Saini SS
J Allergy Clin Immunol; 2007 May; 119(5):1181-8. PubMed ID: 17335884
[TBL] [Abstract][Full Text] [Related]
13. Laboratory markers of mast cell and basophil activation in monitoring rush immunotherapy in bee venom-allergic children.
Cichocka-Jarosz E; Dorynska A; Pietrzyk JJ; Spiewak R
Immunotherapy; 2011 Aug; 3(8):1013-7. PubMed ID: 21843104
[TBL] [Abstract][Full Text] [Related]
14. Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study.
Eržen R; Košnik M; Silar M; Korošec P
Allergy; 2012 Jun; 67(6):822-30. PubMed ID: 22469017
[TBL] [Abstract][Full Text] [Related]
15. Predicting side-effects in venom immunotherapy by basophil activation?
Eberlein-König B; Schmidt-Leidescher C; Behrendt H; Ring J
Allergy; 2006 Jul; 61(7):897. PubMed ID: 16792593
[No Abstract] [Full Text] [Related]
16. Effect on cell surface markers following allergen-induced desensitization of human whole-blood basophils.
Lund G; Jacobi H; Skov PS; Holm J; Lund K
Int Arch Allergy Immunol; 2010; 153(4):323-34. PubMed ID: 20558998
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy.
Abuaf N; Rostane H; Rajoely B; Gaouar H; Autegarden JE; Leynadier F; Girot R
Clin Exp Allergy; 2008 Jun; 38(6):921-8. PubMed ID: 18331364
[TBL] [Abstract][Full Text] [Related]
18. Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy.
Korošec P; Žiberna K; Šilar M; Dežman M; Čelesnik Smodiš N; Rijavec M; Kopač P; Eržen R; Lalek N; Bajrović N; Košnik M; Zidarn M
Clin Exp Allergy; 2015 Oct; 45(10):1579-89. PubMed ID: 26046807
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance.
Bavbek S; Ikincioğullari A; Dursun AB; Guloğlu D; Arikan M; Elhan AH; Misirligil Z
Int Arch Allergy Immunol; 2009; 150(3):261-70. PubMed ID: 19494523
[TBL] [Abstract][Full Text] [Related]
20. Analysis of basophil activation by flow cytometry in pediatric house dust mite allergy.
González-Muñoz M; Villota J; Moneo I
Pediatr Allergy Immunol; 2008 Jun; 19(4):342-7. PubMed ID: 18266832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
